NCT06253988

Brief Summary

the research highlight the effectiveness of probiotics as adjuncts to SRP in the treatment of periodontitis stage III grade C molar-incisor pattern

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
65

participants targeted

Target at below P25 for phase_3

Timeline
Completed

Started Jan 2023

Shorter than P25 for phase_3

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2023

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2023

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2023

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

January 9, 2024

Completed
1 month until next milestone

First Posted

Study publicly available on registry

February 12, 2024

Completed
Last Updated

February 12, 2024

Status Verified

February 1, 2024

Enrollment Period

1 month

First QC Date

January 9, 2024

Last Update Submit

February 9, 2024

Conditions

Keywords

PeriodontitisAgg. actinomycetemcomitansJP2 genotypePCRlocal delivery drugprobiotics

Outcome Measures

Primary Outcomes (3)

  • quantitative assessment of A. actinomycetemcomians levels by picogram

    Microbiological evaluation by picogram

    at baseline (before treatment) used by conventional PCR

  • Assessment of clinical periodontal parameter : Probing pocket Depth (PPD) by mm

    Clinical evaluation mm

    at base line , 1 , 3 , 6 months

  • Assessment of clinical periodontal parameter : Clinical Attachment Level (CAL) by mm

    Clinical evaluation by "mm"

    at base line , 1 , 3 , 6 months

Secondary Outcomes (1)

  • quantitative assessment of A. actinomycetemcomians levels by picogram

    baseline ,1 ,3 and 6 months

Study Arms (2)

Group probiotic

ACTIVE COMPARATOR

received conventional periodontal treatment combined with topically applied probiotic

Drug: Probiotic Formula

Group placebo

PLACEBO COMPARATOR

received conventional periodontal treatment only.

Drug: placebo formula

Interventions

intra-pocket formula (local delivery drug)

Also known as: A mixture of Lactobacillus brevis and Lactobacillus plantarum
Group probiotic

intra-pocket formula (local delivery drug)

Also known as: placebo
Group placebo

Eligibility Criteria

Age10 Years - 28 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • patients have periodontitis stage III grade C molar-incisor pattern .

You may not qualify if:

  • Pregnant or nursing women,
  • smokers,
  • patients received periodontal therapy,
  • systemic antimicrobials or anti-inflammatory drugs in the last six
  • patients with unacceptable oral hygiene

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Alazhar university ,faculty of Dental Medicine

Asyut, 0000, Egypt

Location

Related Links

MeSH Terms

Conditions

Periodontal DiseasesPeriodontitis

Condition Hierarchy (Ancestors)

Mouth DiseasesStomatognathic Diseases

Study Officials

  • Ibrahim H Ibrahim, Ass.prof.

    Al-Azhar University

    PRINCIPAL INVESTIGATOR
  • Mohamed A EL-Mokhtar, Prof

    Assiut University

    STUDY DIRECTOR
  • Mohamed F Edrees, prof.

    Al-Azhar University

    PRINCIPAL INVESTIGATOR
  • Heba A Hammad, Ass.prof

    Assiut University

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Sixty-five patients having periodontitis stage III grade C molar-incisor pattern. Screening for A. actinomycetemcomians (A.a) and the JP2 genotype was done using conventional polymerase chain reaction (PCR). Patients positive for (A. a) were randomly divided into two groups. Group I: received conventional periodontal treatment combined with topically applied probiotic, while Group II: received conventional periodontal treatment only. Both groups were evaluated microbiologically and clinically.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant lecturere of oral medicine ,periodontology departement at sphinx university

Study Record Dates

First Submitted

January 9, 2024

First Posted

February 12, 2024

Study Start

January 1, 2023

Primary Completion

February 1, 2023

Study Completion

September 30, 2023

Last Updated

February 12, 2024

Record last verified: 2024-02

Data Sharing

IPD Sharing
Will share

Effect of probiotics on periodontitis stage III grade C molar-incisor pattern

Shared Documents
SAP
Time Frame
1 month
Access Criteria
DOI: 10.21203/rs.3.rs-3837892/v1
More information

Locations